# US 2021/0198707 A1 · Method for enzymatic preparation of fludarabine phosphate

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0198707 A1
- Document ID: US20210198707A1
- Status: Published application
- Kind: A1
- Application number: 16/070,497
- Filed: 2016-01-20
- Published: 2021-07-01
- Earliest claimed: 2016-01-20
- Assignees: Zhejiang Hisun Pharmaceutical Co., Ltd.
- Applicants: Zhejiang Hisun Pharmaceutical Co., Ltd.
- Inventors: Deijin Fu; Yong Yang; Wei Yan; Weijiang Wen; Xiande Gu; Hua Chen; Xiaojun Xiaojun; Ling Zhang; Kaijun Wang
- Web page: https://patentgrep.com/patent/US20210198707A1

## CPC

- C12P 17/182: {Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system (alloxazine or isoalloxazine, e.g. riboflavine C12P25/00)}
- C12N 9/1205: {Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases}
- C12P 19/32: having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
- C12Y 207/01028: Triokinase (2.7.1.28)
- C12Y 207/02001: Acetate kinase (2.7.2.1)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

A method for enzymatic preparation of fludarabine phosphate, comprising reaction of fludarabine with a high-energy phosphate compound under the action of deoxyribonucleic acid kinase. According to said method, acetate kinase and acetyl phosphate free acid or acetyl phosphate are also added. The technical problems present in the existing processes are successfully addressed by employing the enzymatic process to prepare the fludarabine phosphate. The usage of the high-energy phosphate compound is reduced by means of adding acetate kinase to recycle and regenerate a small amount of the high-energy phosphate compound, thereby reducing the generation of by-products having similar structures to the fludarabine phosphate, enhancing the operation convenience of purification steps in the industrial production of the fludarabine phosphate. The process is environment friendly, the reaction conditions are moderate, the cost is low, and the yield and the purity of the product obtained are high.

## Claims

### Claim 1

A method for enzymatic preparation of fludarabine phosphate, comprising a reaction of fludarabine with a high-energy phosphate compound under the action of a deoxyribonucleic acid kinase, wherein the method further comprises adding an acetate kinase and an acetyl phosphate free acid or an acetyl phosphate.

### Claim 2 (depends on 1)

The method according to claim 1, characterized in that the method comprises the following steps:
(1) Adding a high-energy phosphate compound and an acetyl phosphate free acid or an acetyl phosphate to a fludarabine-containing reactant solution;
(2) Adding a deoxyribonucleic acid kinase and an acetate kinase to the solution obtained in step (1).

### Claim 3 (depends on 1)

The method according to claim 1, wherein the molar ratio of the acetyl phosphate free acid or acetyl phosphate to the fludarabine is (1.0-3.0):1; preferably (1.5-2.5):1.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the high-energy phosphate compound is added in an amount of 0.001-0.003 mol·L−1.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the acetyl phosphate is acetyl phosphate dilithium.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the high-energy phosphate compound is selected from the group consisting of the free acid of ATP, the free acid of ADP, the salt of ATP and the salt of ADP; preferably, the high-energy phosphate compound is ATP disodium salt.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the deoxyribonucleic acid kinase and the acetate kinase are added in the form of a thallus, a thallus crushing liquid, or an immobilized enzyme.

### Claim 8 (depends on 7)

The method according to claim 7, wherein in the step (1), a soluble salt of Mg2+ is added to the fludarabine-containing reactant solution; preferably, the soluble salt of Mg2+ is MgCl2.6H2O or MgCl2.

### Claim 9 (depends on 1)

The method according to claim 1, wherein during the reaction, the pH is adjusted to 6.0-9.0; preferably, the pH is adjusted to 7.5-8.5.

### Claim 10 (depends on 1)

The method according to claim 1, wherein the reaction temperature is 30-45° C.; preferably, the reaction temperature is 37-40° C.

### Claim 11 (depends on 2)

The method according to claim 2, wherein the molar ratio of the acetyl phosphate free acid or acetyl phosphate to the fludarabine is (1.0-3.0):1; preferably (1.5-2.5): 1.

### Claim 12 (depends on 2)

The method according to claim 2, wherein the high-energy phosphate compound is added in an amount of 0.001-0.003 mol·L−1.

### Claim 13 (depends on 2)

The method according to claim 2, wherein the acetyl phosphate is acetyl phosphate dilithium.

### Claim 14 (depends on 3)

The method according to claim 3, wherein the acetyl phosphate is acetyl phosphate dilithium.

### Claim 15 (depends on 4)

The method according to claim 4, wherein the acetyl phosphate is acetyl phosphate dilithium.

### Claim 16 (depends on 2)

The method according to claim 2, wherein the high-energy phosphate compound is selected from the group consisting of the free acid of ATP, the free acid of ADP, the salt of ATP and the salt of ADP; preferably, the high-energy phosphate compound is ATP disodium salt.

### Claim 17 (depends on 3)

The method according to claim 3, wherein the high-energy phosphate compound is selected from the group consisting of the free acid of ATP, the free acid of ADP, the salt of ATP and the salt of ADP; preferably, the high-energy phosphate compound is ATP disodium salt.

### Claim 18 (depends on 2)

The method according to claim 2, wherein the deoxyribonucleic acid kinase and the acetate kinase are added in the form of a thallus, a thallus crushing liquid, or an immobilized enzyme.

### Claim 19 (depends on 2)

The method according to claim 2, wherein during the reaction, the pH is adjusted to 6.0-9.0; preferably, the pH is adjusted to 7.5-8.5.

### Claim 20 (depends on 2)

The method according to claim 2, wherein the reaction temperature is 30-45° C.; preferably, the reaction temperature is 37-40° C.
